Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

CXCL5 and thyroid cancer are reported together in 1 article.

Gene

CXCL5

HGNC
HGNC:10642
9articles
9mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
216articles
216mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

1 records shown · first 60

Genome-wide transcriptome analysis and drug target discovery reveal key genes and pathways in thyroid cancer metastasis.

PMID 39996058 | PMCID PMC11847698 | DOI 10.3389/fendo.2025.1514264 · Frontiers in endocrinology · 2025 · 4 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneCXCL5“Notably, IL-6-mediated inflammatory and PD-L1 pathways were highly active in Met cells with increased secretion of pro-inflammatory and pro-metastatic cytokines such as CCL2, CCL11, IL5, IL6, and CXCL5.”0.98hgnc_dict_v1
phenotypethyroid cancer“Genome-wide transcriptome analysis and drug target discovery reveal key genes and pathways in thyroid cancer metastasis.”0.98phenotype_alias_lexicon_v2
geneCCL2“Notably, IL-6-mediated inflammatory and PD-L1 pathways were highly active in Met cells with increased secretion of pro-inflammatory and pro-metastatic cytokines such as CCL2, CCL11, IL5, IL6, and CXCL5.”0.98hgnc_dict_v1
geneCCL11“Notably, IL-6-mediated inflammatory and PD-L1 pathways were highly active in Met cells with increased secretion of pro-inflammatory and pro-metastatic cytokines such as CCL2, CCL11, IL5, IL6, and CXCL5.”0.98hgnc_dict_v1